SSKN Stock Analysis: Buy, Sell, or Hold?
SSKN - Strata Skin Sciences, Inc. Common Stock
$0.19
-0.13 (-39.99%)
▼
5d:
-84.69%
30d:
-85.4%
90d:
-86.04%
WAIT
LOW Confidence
Analysis Updated: Feb 18, 2026 12:00 AM ET
Earnings: Mar 26, 2026
0d
Get Alerted When SSKN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SSKN is down 84.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SSKN is down 84.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SSKN is currently trading at $0.19, which is considered fair based on recent price action.
Technical Outlook: Technically, SSKN is in a downtrend. The price is currently testing key support at $0.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 40.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.80 (+5590.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SSKN is in a downtrend. The price is currently testing key support at $0.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 40.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.80 (+5590.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
42/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-40.0%)
- BULLISH: Trading 5590.2% below Wall St target ($10.80)
- WARNING: Recommendation downgraded due to -84.7% 5-day decline - wait for stabilization
Support & Resistance Levels
Support Level
$0.24
Resistance Level
$1.32
Current Trend
Downtrend
Technical data as of
Feb 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.15
Wall Street Target
$10.80
(+5590.2%)
Revenue Growth (YoY)
-21.2%
Profit Margin
-35.1%
Share & Embed Analysis
Last updated: May 08, 2026 1:42 PM ET
Data refreshes hourly during market hours. Next update: 2:42 PM
Data refreshes hourly during market hours. Next update: 2:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SSKN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 58 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 63 BUY |
